Or perhaps he limited shareholders to 1 question because of
Or perhaps he limited shareholders to 1 question because of the ridiculous shareholder questions asked in the Sept 2014 Business Update Call, including:
1. If a RS isn't necessary to uplist, then we assume LymPro and Eltoprazine are up for discussion as being sold... you don't have to comment on whether they have been sold to one company or another, but could you address if this is a consideration?
2. When would you expect the company to report a profit? That would include anything... the sale of the diagnostic unit, the sale of LymPro... anything.
What serious investor would ask such questions and waste Gerald's time, knowing there is no way he could answer.
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Arcutis' ZORYVE® Celebrated with Allure's Esteemed Award Arcutis Biotherapeutics, Inc. proudly announces that its groundbreaking medication, ZORYVE® (roflumilast), has been awarded the highly esteemed Allure Best of Beauty Breakthrough Award. This recognition marks ZORYVE as a pioneering product, being the first FDA-approved topical treatment for atopic dermatitis,...
Continue Reading
West Monroe Appoints John Rosato to Transform Technology Division Firm invests to rapidly scale its technology prowess, building on an already strong foundation of experienced capabilities and leadership. West Monroe, a global business and technology consulting firm, is pleased to announce the appointment of John Rosato as its new lead for Technology & Experience. With...
Continue Reading
Gemini Space Station Announces Initial Public Offering Gemini Space Station, Inc. today declared its intention to conduct an initial public offering, offering 16,666,667 shares of Class A common stock as part of a filing submitted to the U.S. Securities and Exchange Commission (SEC). The company aims to solidify its place within the competitive crypto market through this...
Continue Reading
Overview of Public Disclosure in the Context of Renewi Plc The disclosure of ownership positions is crucial under the Takeover Code. Companies, like Renewi Plc, need to comply with strict regulations to inform the public about their shareholders and significant ownership stakes. This article delves into the recent disclosure made by Rathbones Group Plc regarding their...
Continue Reading
Important Update for Nextracker Investors In recent events, Nextracker Inc. has found itself at the center of a class action securities lawsuit, making it crucial for investors to stay informed about their rights and potential actions. This comes from Levi & Korsinsky, LLP, a law firm with significant experience in handling complex securities litigation. Understanding the...
Continue Reading
